Skip to main content
Top
Published in: Diabetologia 10/2005

01-10-2005 | Commentary

Type 1 diabetes: treatment without tears?

Author: S. A. Amiel

Published in: Diabetologia | Issue 10/2005

Login to get access

Excerpt

The tight relationship between intensified insulin therapy for type 1 diabetes and increased risk of severe hypoglycaemia is axiomatic. This assumption is repeated in paper after paper, usually quoting the DCCT, in which patients allocated randomly to the intensive therapy arm of the study showed a three-fold increase in severe hypoglycaemia [1]. But the DCCT, which demonstrated beyond doubt that improved glycaemic control reduced the risk of microvascular complications [2], reported its findings in 1993. It would be a sad reflection on the art and science of diabetes care if we had not moved forwards since then. …
Literature
1.
go back to reference The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450–459 The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450–459
2.
go back to reference The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986 The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
3.
go back to reference Sämann A, Mühlhauser I, Bender R, Kloos C, Müller UA (2005) Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia DOI 10.1007/s00125-005-1905-1 Sämann A, Mühlhauser I, Bender R, Kloos C, Müller UA (2005) Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia DOI 10.​1007/​s00125-005-1905-1
4.
go back to reference Mühlhauser I, Jörgens V, Berger M et al (1983) Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25:470–476PubMed Mühlhauser I, Jörgens V, Berger M et al (1983) Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25:470–476PubMed
5.
go back to reference Berger M, Cuppers HJ, Hegner H, Jorgens V, Berchtold P (1982) Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 2:77–91 Berger M, Cuppers HJ, Hegner H, Jorgens V, Berchtold P (1982) Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 2:77–91
6.
go back to reference Müller UA, Femerling M, Reinauer KM et al (1999) Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care 22(Suppl 2):B29–B34PubMed Müller UA, Femerling M, Reinauer KM et al (1999) Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care 22(Suppl 2):B29–B34PubMed
7.
go back to reference Mühlhauser I, Bott U, Overmann H (1995) Liberalized diet in patients with type 1 diabetes. J Intern Med. 237:591–597PubMed Mühlhauser I, Bott U, Overmann H (1995) Liberalized diet in patients with type 1 diabetes. J Intern Med. 237:591–597PubMed
8.
go back to reference Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ (1995) Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18:625–630PubMed Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ (1995) Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18:625–630PubMed
9.
go back to reference DAFNE Study Group (2002) Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 325:746 DAFNE Study Group (2002) Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 325:746
11.
go back to reference Shearer A, Bagust A, Sanderson D, Heller S, Roberts S (2004) Effectiveness of flexible intensive insulin management to enable dietary freedom in people with type1 diabetes in the UK. Diabet Med 21:460–467CrossRefPubMed Shearer A, Bagust A, Sanderson D, Heller S, Roberts S (2004) Effectiveness of flexible intensive insulin management to enable dietary freedom in people with type1 diabetes in the UK. Diabet Med 21:460–467CrossRefPubMed
Metadata
Title
Type 1 diabetes: treatment without tears?
Author
S. A. Amiel
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1923-z

Other articles of this Issue 10/2005

Diabetologia 10/2005 Go to the issue

Letter

Comment

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.